Amgen (AMGN)
Amgen Capital Expenditures: 144.00M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AMGN Capital Expenditures Rankings
| Overall | 7th percentile | 4103 of 4450 |
| Sector | 1st percentile | 497 of 507 in Healthcare |
| Industry | 0th percentile | 157 of 157 in Biotechnology |
AMGN Capital Expenditures Range, Past 5 Years
| Minimum | 94.00M | Mar 2010 |
| Maximum | 402.00M | Jun 2007 |
| Average | 171.75M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these AMGN related companies
AMGN News
$AMGN http://stks.co/3zIU Odds for daily bounce from 50sma and weekly 20sma and for possible swing trade http://stks.co/3zIV
about 2 days ago by xpertstocktrader
about 2 days ago by xpertstocktrader
$AMGN Mentioned more than normal on StockTwits - Currently at 3 x average daily social activity
about 3 days ago by TradeIdeasQuant
about 3 days ago by TradeIdeasQuant
$AMGN 69.15 a tough nut to crack, past resistance, but has that look it wants more
about 3 days ago by harmongreg
about 3 days ago by harmongreg
Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen; Raises AFFY Target to $21
May 21, 12:17PM Street Insider
May 21, 12:17PM Street Insider
$IBB $XHB $SPY $XLK $AMGN
4 Industry Groups Beating the S&P 500
http://stks.co/3tZG
about 9 days ago by TomAspray
about 9 days ago by TomAspray
$AMGN Mentioned more than normal on StockTwits - Currently at 4 x average daily social activity
about 10 days ago by TradeIdeasQuant
about 10 days ago by TradeIdeasQuant
$AMGN http://stks.co/3sFt UPDATE: Asc Triangle #Pattern breakout target. #Wave 5 UP & 3 DOWN scenarios targets. Long Jun calls
about 10 days ago by RatioCynic
about 10 days ago by RatioCynic
$AMGN http://stks.co/3s4u Nice daily continuation pattern . So far own way chart http://stks.co/3s4v
about 10 days ago by xpertstocktrader
about 10 days ago by xpertstocktrader
Amgen (AMGN) Says AMG 103 Achieves High-Rate of CR in B-Precursor ALL Following Phase 2 Data
May 16, 6:05PM Street Insider
May 16, 6:05PM Street Insider
Amgen (AMGN) Updates on Exploratory Biomarker Analysis for AMG 102 Response Predictor
May 16, 6:04PM Street Insider
May 16, 6:04PM Street Insider
$AMGN http://stks.co/3oda BIG PICTURE! Symm Triangle #Pattern & #Wave targets. 15 Yr rising channel. Bullish $Flows.
about 13 days ago by RatioCynic
about 13 days ago by RatioCynic
Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
May 01, 5:03PM PR Newswire
May 01, 5:03PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AMGN | 69.05 | -0.05 | -0.07% | 54.16B |
| AMG | 103.47 | -0.33 | -0.32% | 5.356B |
| AME | 49.22 | -0.44 | -0.89% | 7.911B |
| AMD | 6.22 | +0.20 | +3.32% | 4.350B |
| AIQ | 1.05 | -0.02 | -1.87% | 55.99M |
| AINV | 7.46 | -0.03 | -0.40% | 1.470B |
| AIN | 18.72 | +0.45 | +2.46% | 585.94M |
| AIMC | 17.11 | -0.24 | -1.38% | 460.94M |
| ALC | 14.57 | -0.13 | -0.88% | 334.67M |
| ALB | 61.43 | +0.94 | +1.55% | 5.464B |
